Company / Current Assets per Share
Gossamer Bio, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.74
FY2025
5-year range
$0.74 / $4.43
FY2021-FY2025
Trend
-46.2%
vs FY2024
Sector context
#202 of 210
Health Care
What the data says
Among 210 Health Care companies, Gossamer Bio, Inc. is in the bottom 4% for current assets per share. Current Assets per Share has declined for 5 consecutive years, from $7.62 in FY2020 to $0.74 in FY2025.
Based on SEC 10-K filings.
0.74 in FY2025 with a 5-year CAGR of -37.3%.
Declined from $2.01 to $0.74 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -37.9%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 210This company $0.74 Sector average $170.65
▼
-99.6% below sector average
Key checks
Key Insights
- Gossamer Bio, Inc.'s current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 46.2% year-over-year.
- Ranks #202 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | -46.2% |
| FY2024 | $1.37 | -31.5% |
| FY2023 | $2.01 | -35.1% |
| FY2022 | $3.10 | -30.2% |
| FY2021 | $4.43 | -41.9% |
| FY2020 | $7.62 | +2.0% |
| FY2019 | $7.48 | -79.0% |
| FY2018 | $35.66 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026